Navigation Links
Neurochem announces eprodisate (KIACTA(TM)) receives acknowledgement of complete response and is granted Class 2 review
Date:12/6/2007

ECUBLENS, Switzerland, Dec. 6 /PRNewswire-FirstCall/ - Neurochem (International) Limited (Neurochem), a wholly-owned subsidiary of Neurochem Inc. (NASDAQ: NRMX; TSX: NRM), announces that the Company has received an acknowledgement from the United States Food and Drug Administration (FDA) that Neurochem's response to the July 2007 approvable letter for the New Drug Application (NDA) for eprodisate (KIACTA(TM)) for the treatment of Amyloid A (AA) amyloidosis is a complete, Class 2 response. The PDUFA (Prescription Drug User Fee Act) goal date by which the FDA is expected to render a decision is April 2, 2008.

The NDA for approval of eprodisate (KIACTA(TM)) for the treatment of AA amyloidosis was filed in February 2006. The Company submitted its response to the second approvable letter last September and this response has been acknowledged as complete by the FDA, allowing for the Class 2 review.

"We look forward to further productive interactions with the FDA as we enter late-stage discussions on our marketing application," said Dr. Francesco Bellini, Neurochem Inc.'s Chairman, President and CEO.

About eprodisate (KIACTA(TM))

Eprodisate (KIACTA(TM)) was investigated in an international, randomized, double-blind, placebo-controlled, and parallel-designed Phase II/III clinical trial in which 183 AA amyloidosis patients were enrolled at 27 sites around the world (Eprodisate for AA Amyloidosis Trial, EFAAT). Patients who completed the clinical trial were eligible for enrollment in an ongoing open-label extension study, some of whom have now been receiving eprodisate (KIACTA(TM)) for more than six years.

In September 2006, the European Medicines Agency (EMEA) confirmed that it had commenced
'/>"/>

SOURCE NEUROCHEM INC.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Neurochem reports results for third quarter of fiscal 2007
2. Neurochem announces departure of Dr. Philippe Calais, President, Global Business
3. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
4. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
5. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
6. HEI, Inc. Announces Sale of RFID Division Assets
7. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
8. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
9. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
10. Brooke Franchise Corporation Announces Selected July Results
11. Manor Care, Inc. Announces Record Date for Special Stockholder Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... Moffitt Cancer Center and colleagues at Louisiana State University ... that require immediate therapy. It relies on understanding the ... is to better predict a prostate cancer,s aggressiveness to ... published in the online journal PLOS ONE ... accounts for 20 percent of all cancers and 9 ...
(Date:6/19/2013)... Brightree LLC , the leading ... for the post-acute care industry, has been ranked for the ... Healthcare Informatics 100 (HCI 100) list. This prestigious list ... in terms of revenue during the last fiscal year. Since ... 85% annually, and the company has built its organization to ...
(Date:6/19/2013)... Kansas City, MO (PRWEB) June 19, 2013 Kansas ... as part of Main Street Day . A section of ... and pedestrian traffic during the afternoon of the event. The ... to host the event, which will help Kansas City join the ... have used Ciclovia as a tool to foster community vibrancy and ...
(Date:6/19/2013)... Louis, MO (PRWEB) June 19, 2013 ... organization, partnered with ARAMARK Healthcare Technologies to help ... management plan with savings of more than 17 ... and maintenance service expenditures. , “Driving economies of ... top medical equipment management challenges facing multi-site providers,” ...
(Date:6/19/2013)... Crawley, UK-- New data, published today in ... Britain are experiencing less sex, and less satisfying ... counterparts1, because they are considerably less likely to ... called vaginal atrophy1. , The first-of-its-kind study, called ... Relationships (CLOSER) study, showed that British post-menopausal women ...
Breaking Medicine News(10 mins):Health News:Moffitt Cancer Center researchers identify genetic variants predicting aggressive prostate cancers 2Health News:Brightree Debuts on List of Top 100 Healthcare Technology Companies 2Health News:Brightree Debuts on List of Top 100 Healthcare Technology Companies 3Health News:Main Street Corridor Development Corporation and BikeWalkKC Partner to Host Main Street Day and Kansas City’s First Ciclovia 2Health News:Main Street Corridor Development Corporation and BikeWalkKC Partner to Host Main Street Day and Kansas City’s First Ciclovia 3Health News:Amerinet Partners with ARAMARK Healthcare Technologies to Help Pacific Medical Centers Save 17 Percent and Better Manage System-Wide Equipment Program 2Health News:British women 50 percent less likley to recieve treatment for common menopausal symptoms 2
... E. coli infection from tainted spinach. E. coli experts like ... University// of British Columbia in Canada, can explain how the ... Finlay's lab determined the molecular structure of E. coli, information ... as well as a vaccine for cattle, because E. coli ...
... seem to be at significantly greater risk of developing ... of print in the journal Gut. ,The ... 1250 of whom were identical. The twins completed a ... ever had IBS. ,This information was then ...
... agent involved in food poisoning and account for hundreds ... invades by stealth and hides from macrophages before entering ... macrophages are the cells meant to detect such bacteria. ... turning predator cells to prey complicit in promoting infection, ...
... up to 23,000 junior doctor training posts in the UK next ... [JDC], Dr Tom Dolphin, said ,"The BMA is delighted ... number of training posts, and this goes a long way towards ... concerned about what happens to those who do not get into ...
... The injection is safe when performed by physicians experienced ... and sustained, according to the one-year, multi-center cohort study. ... study, the mean pain score on a 10-point visual ... 1.4 at two weeks, 0.5 at 24 weeks, and ...
... officials have reported the death of two women after consumption ... had previous history of health problems.//, ,Agriculture Commissioner Tommy ... they did something they shouldn’t have done and they lost ... a major health threat. ,The DeKalb Farmers’ Market ...
Cached Medicine News:Health News:Restricted Fetal Growth Increases Risk of Irritable Bowel Syndrome 2Health News:Salmonella Bacteria Are Deceptive 2Health News:Sacroplasty Safe and Effective to Reduce Low Back Pain 2Health News:Sacroplasty Safe and Effective to Reduce Low Back Pain 3
(Date:6/19/2013)... , June 19, 2013 Today ... solutions, introduced the next-generation of its Employer ... allows health plans to provide their employer groups ... health factors, medical and prescription drug claims, network ... (Logo: http://photos.prnewswire.com/prnh/20100621/SF23660LOGO ) "Employer ...
(Date:6/19/2013)... 2013  It may seem like an odd pairing: an ... But these were two of the most talked about topics ... Meeting & Expo that just convened in San ... by some of the top internal medicine experts in the ... research that can not only save lives, but help people ...
(Date:6/18/2013)...  Intercept Pharmaceuticals, Inc.  (NASDAQ: ICPT ), ... and commercialization of novel bile acid therapeutics to treat ... underwritten public offering of 1,730,000 shares of its common ... share.  In addition, Intercept has granted the underwriters a ... shares of common stock. All of the ...
Breaking Medicine Technology:MedeAnalytics Introduces Next-Generation Employer Group and Individual Business Analytics Solution 2"Miracle" Breast Cancer Drug and "Youth Hormone" Pill Steal Show at Prestigious Endocrine Society Conference 2"Miracle" Breast Cancer Drug and "Youth Hormone" Pill Steal Show at Prestigious Endocrine Society Conference 3"Miracle" Breast Cancer Drug and "Youth Hormone" Pill Steal Show at Prestigious Endocrine Society Conference 4Intercept Pharmaceuticals Announces Pricing of Public Offering of Common Stock 2
... Contributing Editor Human papillomaviruses (HPVs) are small, closed ... nucleic acid sequence homology rather than serologic reactivity. ... transmitted pathogens. Of the approximately 50 anogenital ... and intermediate risk types detected in anogenital cancer ...
... Londe, M.D. Contributing Editor Clinical guidelines from the disciplines ... emphasized the importance of cardiac markers in diagnosing or ... cardiac troponins is especially useful in the large fraction ... have negative 12-lead EKGs. About 30% of patients ...
Cached Medicine Technology:Testing for Human Papillomavirus 2Testing for Human Papillomavirus 3Point of Care Cardiac Analyzers Yield Rapid Cardiac Marker Results 2Point of Care Cardiac Analyzers Yield Rapid Cardiac Marker Results 3
Use Streck-Sheath to count and classify white blood cells on the Abbott CELL-DYN® 3000, 3500 and 3700. The shelf life is two years from date of manufacture...
A lytic reagent manufactured for the simultaneous quantitative determinations of hemoglobin and white blood cells. Streck-Lysing Agent III is for use on the Abbott CELL-DYN® 1400 and 1600. The sh...
Streck-CD3500 Hemoglobin/Lyse is a lytic reagent for the quantitative determination of hemoglobin on the Abbott CELL-DYN® 3500 and 3700. The shelf life is two years from the date of manufacture....
Streck-Diluent IIIA is a balanced electrolyte solution manufactured specifically for use as a diluent for blood cell counting and sizing on the Abbott CELL-DYN® 1700. The shelf life is one year f...
Medicine Products: